Researchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial, which aims to evaluate a new treatment for breast cancer in combination with one that is already approved for other types cancers.Â* The new combination is targeted toward treatment of hormone receptor-positive locally advanced cancer (cancer cells that grow and multiply when the estrogen hormone attaches to the hormone receptor) or metastatic breast cancer (cancer that spreads to other parts of the body).
More...
Linear Mode
